• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于复发后生存情况,建立并验证用于预测根治术后晚期及早期复发的进展期胃癌患者预后的列线图。

Development and validation of nomograms for predicting the prognosis of early and late recurrence of advanced gastric cancer after radical surgery based on post-recurrence survival.

机构信息

Department of General Surgery, Shaoxing People's Hospital, Shaoxing, China.

Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Medicine (Baltimore). 2024 May 31;103(22):e38376. doi: 10.1097/MD.0000000000038376.

DOI:10.1097/MD.0000000000038376
PMID:39259073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11142773/
Abstract

In this study, we aimed to explore the risk factors influencing post-recurrence survival (PRS) of early recurrence (ER) and late recurrence (LR) in stage advanced gastric cancer (AGC) patients after radical surgery, respectively, and to develop predictive models in turn. Medical records of 192 AGC patients who recurred after radical gastrectomy were retrospectively reviewed. They were randomly divided into the training and validation set at a ratio of 2:1. Nomograms were built based on risk factors influencing PRS of ER and LR explored by Cox regression analyses, respectively. Concordance index (C-index) values and calibration curves were used to evaluate predictive power of nomograms. Body mass index < 18.5 kg/m2, prealbumin level < 70.1 mg/L, positive lymph nodes ratio ≥ 0.486 and palliative treatment after recurrence were independent risk factors for the prognosis of ER. In contrast, prealbumin level < 170.1 mg/L, CEA ≥ 18.32 μg/L, tumor diameter ≥ 5.5 cm and palliative treatment after recurrence were independent risk factors for the prognosis of LR. The C-index values were 0.801 and 0.772 for ER and LR in the training set, respectively. The calibration curves of validation set showed a C-index value of 0.744 and 0.676 for ER and LR, respectively. Nomograms which were constructed to predict the prognosis of ER and LR of AGC after surgery showed great predictive power and could provide reference for clinicians' treatment strategies to some extent.

摘要

在这项研究中,我们旨在分别探讨影响根治性手术后晚期复发(LR)和早期复发(ER)的进展期胃癌(AGC)患者术后无复发生存(PRS)的风险因素,并依次建立预测模型。回顾性分析了 192 例根治性胃切除术后复发的 AGC 患者的病历资料。将其按 2:1 的比例随机分为训练集和验证集。分别基于 Cox 回归分析探讨的影响 ER 和 LR 的 PRS 的风险因素,建立列线图。使用一致性指数(C-index)值和校准曲线来评估列线图的预测能力。BMI<18.5kg/m2、白蛋白水平<70.1mg/L、阳性淋巴结比例≥0.486 和复发后姑息治疗是 ER 预后的独立危险因素。相比之下,白蛋白水平<170.1mg/L、CEA≥18.32μg/L、肿瘤直径≥5.5cm 和复发后姑息治疗是 LR 预后的独立危险因素。在训练集中,ER 和 LR 的 C-index 值分别为 0.801 和 0.772。验证集的校准曲线显示 ER 和 LR 的 C-index 值分别为 0.744 和 0.676。构建的用于预测术后 AGC 患者 ER 和 LR 预后的列线图具有很好的预测能力,在一定程度上可为临床医生的治疗策略提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/0a7fe330c874/medi-103-e38376-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/d86b9e5a3659/medi-103-e38376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/47f40b65192e/medi-103-e38376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/5a6218dc3c0a/medi-103-e38376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/41215b73ff0f/medi-103-e38376-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/a2255a14dca6/medi-103-e38376-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/4d6fb50c556b/medi-103-e38376-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/c6454d1a6d25/medi-103-e38376-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/0a7fe330c874/medi-103-e38376-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/d86b9e5a3659/medi-103-e38376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/47f40b65192e/medi-103-e38376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/5a6218dc3c0a/medi-103-e38376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/41215b73ff0f/medi-103-e38376-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/a2255a14dca6/medi-103-e38376-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/4d6fb50c556b/medi-103-e38376-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/c6454d1a6d25/medi-103-e38376-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cfd/11142773/0a7fe330c874/medi-103-e38376-g008.jpg

相似文献

1
Development and validation of nomograms for predicting the prognosis of early and late recurrence of advanced gastric cancer after radical surgery based on post-recurrence survival.基于复发后生存情况,建立并验证用于预测根治术后晚期及早期复发的进展期胃癌患者预后的列线图。
Medicine (Baltimore). 2024 May 31;103(22):e38376. doi: 10.1097/MD.0000000000038376.
2
Defining nomograms for predicting prognosis of early and late recurrence in gastric cancer patients after radical gastrectomy.建立用于预测胃癌患者根治性胃切除术后早期和晚期复发预后的列线图。
Medicine (Baltimore). 2023 Oct 20;102(42):e35585. doi: 10.1097/MD.0000000000035585.
3
Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer.开发和验证用于预测 II/III 期胃癌根治性切除术后早期复发的预后列线图。
World J Surg Oncol. 2019 Dec 19;17(1):223. doi: 10.1186/s12957-019-1750-1.
4
Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.预测接受姑息性胃切除术的转移性胃腺癌患者生存的列线图。
BMC Cancer. 2019 Aug 28;19(1):852. doi: 10.1186/s12885-019-6075-5.
5
[Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].[伴有神经侵犯的进展期胃癌预测列线图模型的建立与验证]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Nov 25;23(11):1059-1066. doi: 10.3760/cma.j.cn.441530-20200103-00004.
6
Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy.竞争风险列线图预测胃癌患者 D2 胃切除术后初始局部区域复发。
Radiat Oncol. 2019 Jul 17;14(1):128. doi: 10.1186/s13014-019-1332-y.
7
Risk stratification models incorporating oxidative stress factors to predict survival and recurrence in patients with gastric cancer after radical gastrectomy: A real-world multicenter study.纳入氧化应激因素的风险分层模型预测根治性胃切除术后胃癌患者的生存和复发:一项真实世界多中心研究。
Eur J Surg Oncol. 2024 Dec;50(12):108658. doi: 10.1016/j.ejso.2024.108658. Epub 2024 Sep 3.
8
Machine Learning Prediction of Early Recurrence in Gastric Cancer: A Nationwide Real-World Study.机器学习预测胃癌早期复发:一项全国性真实世界研究。
Ann Surg Oncol. 2025 Apr;32(4):2637-2650. doi: 10.1245/s10434-024-16701-y. Epub 2024 Dec 30.
9
Development of a prognostic oxidative stress-immune-inflammation score and online calculators for predicting survival and recurrence in gastric cancer: a multicenter study.用于预测胃癌生存和复发的预后氧化应激-免疫-炎症评分及在线计算器的开发:一项多中心研究
Surg Endosc. 2025 Apr;39(4):2609-2624. doi: 10.1007/s00464-025-11596-6. Epub 2025 Mar 6.
10
[Risk factors and nomogram construction for predicting long-term survival in hepatoid adenocarcinoma of the stomach].[预测胃肝样腺癌长期生存的危险因素及列线图构建]
Zhonghua Wei Chang Wai Ke Za Zhi. 2025 Feb 25;28(2):157-168. doi: 10.3760/cma.j.cn441530-20240910-00312.

引用本文的文献

1
Prediction of tumor deposits in stage I-III gastric cancer: a clinically applicable nomogram integrating clinicopathology outcomes.I-III期胃癌中肿瘤沉积物的预测:整合临床病理结果的临床适用列线图
Front Med (Lausanne). 2025 May 30;12:1577569. doi: 10.3389/fmed.2025.1577569. eCollection 2025.
2
The efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone in advanced or metastatic gastric or gastroesophageal junction cancer: a meta-analysis of randomized controlled trials.PD-1/PD-L1抑制剂联合化疗与单纯化疗治疗晚期或转移性胃癌或胃食管交界癌的疗效和安全性:一项随机对照试验的荟萃分析
Eur J Clin Pharmacol. 2025 Jun 10. doi: 10.1007/s00228-025-03861-3.
3

本文引用的文献

1
Development and validation of nomogram for predicting early recurrence after radical gastrectomy of gastric cancer.基于胃癌根治术后早期复发预测的列线图的建立与验证。
World J Surg Oncol. 2024 Jan 19;22(1):21. doi: 10.1186/s12957-023-03294-1.
2
Defining a Nomogram for Predicting Early Recurrence in Gastric Cancer Patients After Neoadjuvant Chemotherapy and Radical Gastrectomy.定义用于预测新辅助化疗和根治性胃切除术后胃癌患者早期复发的列线图。
J Gastrointest Surg. 2023 Sep;27(9):1766-1777. doi: 10.1007/s11605-023-05697-7. Epub 2023 May 23.
3
Prognostic Nutritional Index as a Predictor of Prognosis in Postoperative Patients With Gastric Cancer.
Integrating Mendelian randomization and multi-transcriptomic analyses to unveil the genetic association risk of regulatory T cell-mediated free cholesterol and gastric cancer.
整合孟德尔随机化和多转录组分析以揭示调节性T细胞介导的游离胆固醇与胃癌的遗传关联风险
Discov Oncol. 2025 May 22;16(1):864. doi: 10.1007/s12672-025-02739-1.
4
Meta-analysis of the efficacy of applying reduced surgery for the treatment of asymptomatic unresectable advanced gastric cancer.应用缩小手术治疗无症状不可切除进展期胃癌疗效的Meta分析。
BMC Gastroenterol. 2025 Apr 18;25(1):271. doi: 10.1186/s12876-025-03849-4.
5
Development and verification of a radiomics model to forecast Ki67 index and prognosis in advanced gastric tubular adenocarcinoma.预测进展期胃管状腺癌Ki67指数及预后的影像组学模型的开发与验证
BMC Gastroenterol. 2025 Apr 15;25(1):260. doi: 10.1186/s12876-025-03845-8.
6
Comparative study of XGBoost and logistic regression for predicting sarcopenia in postsurgical gastric cancer patients.XGBoost与逻辑回归用于预测胃癌术后患者肌肉减少症的比较研究
Sci Rep. 2025 Apr 14;15(1):12808. doi: 10.1038/s41598-025-98075-z.
预后营养指数作为胃癌术后患者预后预测指标的研究。
In Vivo. 2023 May-Jun;37(3):1290-1296. doi: 10.21873/invivo.13207.
4
Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition).日本胃癌治疗指南 2021(第 6 版)。
Gastric Cancer. 2023 Jan;26(1):1-25. doi: 10.1007/s10120-022-01331-8. Epub 2022 Nov 7.
5
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.《胃癌,第2.2022版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南》
J Natl Compr Canc Netw. 2022 Feb;20(2):167-192. doi: 10.6004/jnccn.2022.0008.
6
Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment.胃癌患者接受根治性治疗时前白蛋白水平的临床意义。
J Gastrointest Cancer. 2023 Mar;54(1):27-34. doi: 10.1007/s12029-021-00777-w. Epub 2021 Dec 18.
7
Computed Tomography-Based Radiomics Nomogram: Potential to Predict Local Recurrence of Gastric Cancer After Radical Resection.基于计算机断层扫描的影像组学列线图:预测胃癌根治术后局部复发的潜力
Front Oncol. 2021 Sep 2;11:638362. doi: 10.3389/fonc.2021.638362. eCollection 2021.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
Association of Preoperative Serum Carcinoembryonic Antigen and Gastric Cancer Recurrence: A Large Cohort Study.术前血清癌胚抗原与胃癌复发的关联:一项大型队列研究
J Cancer. 2021 Jan 1;12(2):397-403. doi: 10.7150/jca.47899. eCollection 2021.
10
Recurrence pattern and its predictors for advanced gastric cancer after total gastrectomy.全胃切除术后进展期胃癌的复发模式及其预测因素。
Medicine (Baltimore). 2020 Dec 18;99(51):e23795. doi: 10.1097/MD.0000000000023795.